ROLE OF CITRIC-ACID IN PRIMARY HYPERPARATHYROIDISM WITH RENAL LITHIASIS

被引：8

作者：

ALVAREZARROYO, MV ^{[1
]}

TRABA, ML ^{[1
]}

RAPADO, A ^{[1
]}

DELAPIEDRA, C ^{[1
]}

机构：

[1] FDN JIMENEZ DIAZ,UNIDAD METABOL LAB,AVDA REYES CATOLICO 2,E-28040 MADRID,SPAIN

来源：

UROLOGICAL RESEARCH | 1992年 / 20卷 / 01期

关键词：

PRIMARY HYPERPARATHYROIDISM; RENAL LITHIASIS; CITRATE;

D O I：

10.1007/BF00294345

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Nephrolithiasis is presented in 18-40% of patients with primary hyperparathyroidism. Our work suggests that citrate. an inhibitor of calcium salts, could be involved in the presence of renal lithiasis because hyperparathyroid stone formers show less citrate elimination than nonstone formers.

引用

页码：88 / 90

页数：3

共 8 条

[1] IMPORTANCE OF CIRCULATING 1,25-DIHYDROXYVITAMIN-D IN THE PATHOGENESIS OF HYPERCALCIURIA AND RENAL-STONE FORMATION IN PRIMARY HYPERPARATHYROIDISM [J].

BROADUS, AE ;

HORST, RL ;

LANG, R ;

LITTLEDIKE, ET ;

RASMUSSEN, H .

NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (08) :421-426

[2]

HODGKINSON A, 1963, CLIN SCI, V24, P167

[3]

MINISOLA S, 1989, MINER ELECTROL METAB, V15, P303

[4] A LACK OF UNIQUE PATHOPHYSIOLOGIC BACKGROUND FOR NEPHROLITHIASIS OF PRIMARY HYPERPARATHYROIDISM [J].

PAK, CYC ;

NICAR, MJ ;

PETERSON, R ;

ZERWEKH, JE ;

SNYDER, W .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (03) :536-542

[5]

PAK CYC, 1979, INVEST UROL, V17, P146

[6] HYPOCITRATURIA IN CALCIUM NEPHROLITHIASIS [J].

RUDMAN, D ;

KUTNER, MH ;

REDD, SC ;

WATERS, WC ;

GERRON, GG ;

BLEIER, J .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (06) :1052-1057

[7] NEPHROLITHIASIS AND BONE INVOLVEMENT IN PRIMARY HYPERPARATHYROIDISM [J].

SILVERBERG, SJ ;

SHANE, E ;

JACOBS, TP ;

SIRIS, ES ;

GARTENBERG, F ;

SELDIN, D ;

CLEMENS, TL ;

BILEZIKIAN, JP .

AMERICAN JOURNAL OF MEDICINE, 1990, 89 (03) :327-334

[8]

WATSON L, 1959, P ROY SOC MED, V52, P349

← 1 →